Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Second auto-SCT is safe and effective salvage therapy for relapsed multiple myeloma.
Olin RL, Vogl DT, Porter DL, Luger SM, Schuster SJ, Tsai DE, Siegel DL, Cook RJ, Mangan PA, Cunningham K, Stadtmauer EA. Olin RL, et al. Among authors: porter dl. Bone Marrow Transplant. 2009 Mar;43(5):417-22. doi: 10.1038/bmt.2008.334. Epub 2008 Oct 13. Bone Marrow Transplant. 2009. PMID: 18850013 Free PMC article.
Autologous stem-cell transplant after conventional dose adjuvant chemotherapy for high-risk breast cancer: impact on the delivery of local-regional radiation therapy.
Moore HC, Mick R, Solin LJ, Sickles C, Mangan PA, Luger SM, Fox KR, Schuchter LM, Loh E, Porter DL, Schuster S, Buzby GP, Glatstein E, Silberstein LE, Stadtmauer EA. Moore HC, et al. Among authors: porter dl. Ann Oncol. 1999 Aug;10(8):929-36. doi: 10.1023/a:1008393204854. Ann Oncol. 1999. PMID: 10509154 Free article. Clinical Trial.
Stem cell transplantation for metastatic breast cancer: analysis of tumor contamination.
Stadtmauer EA, Tsai DE, Sickles CJ, Mick R, Luger SM, Porter DL, Mangan PA, Schuchter LM, Schuster SJ, Loh EY, Magee DA, Sachs RA, Wall ME, Moore J, Buzby GP, Zaleta E, Kamoun M, Silberstein LE. Stadtmauer EA, et al. Among authors: porter dl. Med Oncol. 1999 Dec;16(4):279-88. doi: 10.1007/BF02785874. Med Oncol. 1999. PMID: 10618691 Clinical Trial.
Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and long-term follow-up of 42 adult patients.
Tsai DE, Hardy CL, Tomaszewski JE, Kotloff RM, Oltoff KM, Somer BG, Schuster SJ, Porter DL, Montone KT, Stadtmauer EA. Tsai DE, et al. Among authors: porter dl. Transplantation. 2001 Apr 27;71(8):1076-88. doi: 10.1097/00007890-200104270-00012. Transplantation. 2001. PMID: 11374406
Novel approaches to allogeneic stem cell therapy.
Bhatia V, Porter DL. Bhatia V, et al. Among authors: porter dl. Expert Opin Biol Ther. 2001 Jan;1(1):3-15. doi: 10.1517/14712598.1.1.3. Expert Opin Biol Ther. 2001. PMID: 11727545 Review.
243 results